Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Sumner

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
Journal of Diabetes Science and Technology|May 31, 2014
Short-Term Thermal-Humidity Shock Affects Point-of-Care Glucose Testing: Implications for Health Professionals and PatientsMandy Lam, Richard F Louie, Corbin M Curtis, et al.
Trials|February 12, 2020
A randomised, double-blind, active placebo-controlled, parallel groups, dose-response study of scopolamine hydrobromide (4-6 μg/kg) in patients with major depressive disorderJoseph C C Chen, Rachael L Sumner, Venkat Krishnamurthy Naga, et al.
Frontiers in Pharmacology|March 23, 2026
Low-dose naltrexone as an adjunctive treatment for major depressive disorder: findings from a randomized, double-blind, placebo-controlled hybrid parallel-arm studyBen D Moloney, Anna Forsyth, Rachael L Sumner, et al.
Trials|May 11, 2021
Correction to: MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteersRobin J Murphy, Rachael L Sumner, William Evans, et al.
Trials|April 24, 2021
MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteersRobin J Murphy, Rachael L Sumner, William Evans, et al.
Therapeutic Advances in Psychopharmacology|December 9, 2025
What is it like to microdose LSD for depression? a thematic analysis of participant interviews from an open-label trialCarina Joy Donegan, Dimitri Daldegan-Bueno, Rachael L Sumner, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 9, 2020
Ketamine improves short-term plasticity in depression by enhancing sensitivity to prediction errorsRachael L Sumner, Rebecca McMillan, Meg J Spriggs, et al.
Scientific Reports|May 10, 2023
Acute exercise as a modifier of neocortical plasticity and aperiodic activity in the visual cortexClaire J Cadwallader, Jennifer Steiniger, Patrick S Cooper, et al.
The Journal of Clinical Psychiatry|August 18, 2022
A Randomized Controlled Trial of Intravenous Scopolamine Versus Active-Placebo Glycopyrrolate in Patients With Major Depressive DisorderJoseph C C Chen, Rachael L Sumner, Venkat Krishnamurthy Naga, et al.
Journal of Cardiovascular Electrophysiology|February 12, 2009
A case of long-RP tachycardia: what is the mechanism?Syamkumar M Divakara Menon, Jeff S Healey, Girish M Nair, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Journal of Diabetes Science and Technology|May 31, 2014
Short-Term Thermal-Humidity Shock Affects Point-of-Care Glucose Testing: Implications for Health Professionals and PatientsMandy Lam, Richard F Louie, Corbin M Curtis, et al.
Trials|February 12, 2020
A randomised, double-blind, active placebo-controlled, parallel groups, dose-response study of scopolamine hydrobromide (4-6 μg/kg) in patients with major depressive disorderJoseph C C Chen, Rachael L Sumner, Venkat Krishnamurthy Naga, et al.
Frontiers in Pharmacology|March 23, 2026
Low-dose naltrexone as an adjunctive treatment for major depressive disorder: findings from a randomized, double-blind, placebo-controlled hybrid parallel-arm studyBen D Moloney, Anna Forsyth, Rachael L Sumner, et al.
Trials|May 11, 2021
Correction to: MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteersRobin J Murphy, Rachael L Sumner, William Evans, et al.
Trials|April 24, 2021
MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteersRobin J Murphy, Rachael L Sumner, William Evans, et al.
Therapeutic Advances in Psychopharmacology|December 9, 2025
What is it like to microdose LSD for depression? a thematic analysis of participant interviews from an open-label trialCarina Joy Donegan, Dimitri Daldegan-Bueno, Rachael L Sumner, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 9, 2020
Ketamine improves short-term plasticity in depression by enhancing sensitivity to prediction errorsRachael L Sumner, Rebecca McMillan, Meg J Spriggs, et al.
Scientific Reports|May 10, 2023
Acute exercise as a modifier of neocortical plasticity and aperiodic activity in the visual cortexClaire J Cadwallader, Jennifer Steiniger, Patrick S Cooper, et al.
The Journal of Clinical Psychiatry|August 18, 2022
A Randomized Controlled Trial of Intravenous Scopolamine Versus Active-Placebo Glycopyrrolate in Patients With Major Depressive DisorderJoseph C C Chen, Rachael L Sumner, Venkat Krishnamurthy Naga, et al.
Journal of Cardiovascular Electrophysiology|February 12, 2009
A case of long-RP tachycardia: what is the mechanism?Syamkumar M Divakara Menon, Jeff S Healey, Girish M Nair, et al.
Pageof 10